Oncogenic role of ERV with therapeutic potential
Frontiers in Immunology · 24.04.2026 · 17
DOI: 10.3389/fimmu.2026.1807944 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, online erschienen am 24.04.2026. Verfasst von Pan-Hui Xia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin H…. Hauptthemen laut MEDLINE: Endogenous Retroviruses, Neoplasms, Carcinogenesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Endogenous Retroviruses (ERVs) are originated from ancient exogenous viruses, which integrate into the host genome after infection and persist across all vertebrate lineages. Complete ERV consists of viral genes ( gag , pro , pol , and env ) in the center and two Long Terminal Repeats (LTRs) at both ends, which encode viral structural proteins, critical enzyme, and glycoprotein. ERVs constitute approximately 8% of human genome and function in a wide range of physiological and pathological processes, including embryonic development, inflammation and infection, neurodegenerative diseases, cancers, etc. The expression of ERVs is controlled mainly by epigenetic modification, transcriptional regulation and post-transcriptional modulation, which offered important therapeutic targets. In this review, we reviewed the structure and function of ERVs, summarized recent research advances on how ERVs contribute to cancer initiation and progression, and introduced some therapies targeting ERVs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine…
- Pôle de Recherches Sino-Français en Science du Vivant et Génomique, Laboratory of Molecular Pathology, Shanghai, China.
Zitieren
APA
Xia, P. H., Zhao, W. L., & Xiong, J. (2026). Oncogenic role of ERV with therapeutic potential. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1807944
Vancouver
Xia PH, Zhao WL, Xiong J. Oncogenic role of ERV with therapeutic potential. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1807944
BibTeX
@article{Xia2026,
author = {Xia, Pan-Hui and Zhao, Wei-Li and Xiong, Jie},
title = {Oncogenic role of ERV with therapeutic potential},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1807944}
}
EUVIMED